The Bio Pharma

[...] Diabetes prevention: 5 tips for taking control Changing your lifestyle could be a big step toward diabetes [...]

[...] PharmaRoth Labs, Inc. (OTC: ROTH) is a publicly traded company focused on diabetes prevention and treatments. The Company holds the intellectual property and other exclusive world-wide [...]

[...]  Source: Wall Street Journal © 2014 TheBioPharma.com. TheBioPharma does not provide investment advice. All rights reserved. [...]

[...] : Endocrine Society   © 2014 TheBioPharma.com. TheBioPharma does not provide investment advice. All rights reserved. [...]

[...] and urinary tract infection. FDA © 2014 TheBioPharma.com. TheBioPharma does not provide investment advice. All rights reserved. [...]

[...] Study Results, Mannkind.com © 2014 TheBioPharma.com. TheBioPharma does not provide investment advice. All rights reserved. [...]

[...] levels and improve control of blood glucose levels after meals. “Few controlled clinical trials have examined traditional Chinese medicine’s impact on diabetes, and the findings [...]

[...] had an acceptable cardiovascular risk profile. Safety and efficacy were established in 16 clinical trials of over 9,400 diabetes patients and showed patients had improvements in HbA1c with the drug. [...]

[...] sugar to the normal range without the risk of low blood sugars. Sucanon® has undergone clinical trials in China and Brazil. Sucanon® is approved and is sold as an Over-The-Counter (“OTC& [...]

[...] cause lung cancer. There were more cases of lung cancer among those who received Afrezza in clinical trials than in the control groups, but the numbers were small and far from definitive. MannKind is [...]

[...] nerve, kidney and heart damage. Consider the latest diabetes prevention tips from the American Diabetes Association. Tip 1: Get more physical activity There are many benefits to regular physical [...]

[...] in adults over the age of 20 in the U.S., according to data from the American Diabetes Association. There are questions about how China’s health-care system will hold [...]

[...] for Type II diabetes. Sucanon® is a member of a class of diabetic medications called insulin sensitizers. Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver’s [...]

[...] risk profile. Safety and efficacy were established in 16 clinical trials of over 9,400 diabetes patients and showed patients had improvements in HbA1c with the drug. Dapagliflozin should not be [...]

[...] with a lower risk of type 2 diabetes,” they write. However, Richard Elliott, of Diabetes UK, said: “Even if people who drank more coffee did tend to have a lower risk of type 2, it [...]

[...] age and gender. The overall reduction in risk was comparable to that found in studies of diabetes medications acarbose and metformin, and study participants reported few side effects from the Tianqi [...]

[...] ’s new drug application for Afrezza cited cartridges containing up to three units of injected insulin, and double-strength cartridges with up to six units, when its clinical trial used [...]